# COMO: Cognition Study With HIV+ Patients (CTNPT 015)

> **NCT02144688** · EARLY_PHASE1 · TERMINATED · sponsor: **Marie-Josée Brouillette** · enrollment: 19 (actual)

## Conditions studied

- HIV - Human Immunodeficiency Virus
- Cognitive Symptoms

## Interventions

- **DRUG:** Change in antiretrovirals

## Key facts

- **NCT ID:** NCT02144688
- **Lead sponsor:** Marie-Josée Brouillette
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** In 14 participants who had LP, very low level viremia was found in only 1
- **Last updated:** 2016-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02144688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02144688, "COMO: Cognition Study With HIV+ Patients (CTNPT 015)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02144688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*